Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany
· Delayed Price · Currency is EUR 452.70
-7.90 (-1.72%)
Mar 31, 2025, 2:20 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €116.80 billion as of March 31, 2025. Its market cap has increased by 19.77% in one year.
Market Cap
116.80B
Enterprise Value
108.05B
Revenue
10.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
€452.70
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 116.80B, an increase of 157,988.67%. That is a compound annual growth rate of 24.43%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 56.76B |
| Siemens Healthineers AG | 56.75B |
| Fresenius SE & Co. KGaA | 22.54B |
| Bayer Aktiengesellschaft | 22.17B |
| Sartorius Aktiengesellschaft | 13.70B |
| Fresenius Medical Care AG | 13.48B |
| Carl Zeiss Meditec AG | 5.75B |
| Fielmann Group AG | 3.60B |